Check-Cap LtdMBAIEarnings & Financial Report
Nasdaq · Health Care · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Check-Cap Ltd is a clinical-stage medical technology company specializing in non-invasive colorectal cancer screening solutions. Its core offering is an ingestible imaging capsule that requires no prior bowel preparation, targeting global healthcare markets to boost accessibility of early colon cancer detection for at-risk patient groups.
MBAI Q4 FY2025 Key Financial Metrics
Revenue
$47.9K
Gross Profit
$2.5K
Operating Profit
$1.4K
Net Profit
$1.1K
Gross Margin
5.2%
Operating Margin
2.9%
Net Margin
2.3%
YoY Growth
N/A
Check-Cap Ltd Q4 FY2025 Financial Summary
Check-Cap Ltd reported revenue of $47.9K for Q4 FY2025, with a net profit of $1.1K (up 100.0% YoY) (2.3% margin). Cost of goods sold was $45.5K, operating expenses totaled $1.1K.
Key Financial Metrics
| Total Revenue | $47.9K |
|---|---|
| Net Profit | $1.1K |
| Gross Margin | 5.2% |
| Operating Margin | 2.9% |
| Report Period | Q4 FY2025 |
Income Statement
| Q4 2025 | |
|---|---|
| Revenue | $47940 |
| YoY Growth | N/A |
Balance Sheet
| Q4 2025 | |
|---|---|
| Assets | $184940 |
| Liabilities | $183492 |
| Equity | $1448 |
Cash Flow
| Q4 2025 | |
|---|---|
| Operating CF | $-89228 |